Amir KarimiPourSaryazdi, Mohammad Mahdi Jafari, Majid Pirestani, Seyyed Hojjat Sadeghi, Zeinab Moghadamizad
{"title":"百里醌对热带利什曼原虫/婴儿和利什曼原虫感染巨噬细胞的影响。","authors":"Amir KarimiPourSaryazdi, Mohammad Mahdi Jafari, Majid Pirestani, Seyyed Hojjat Sadeghi, Zeinab Moghadamizad","doi":"10.1007/s11686-023-00713-x","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p><i>Leishmania</i> is a parasitic protozoan that tries to enter and amplify within macrophages. Macrophage cells are also immune defense cells that phagocyte many microbes like bacteria, fungi, as well as parasites like <i>Leishmania</i> spp. However, they are unable to kill this parasite that resides in the phagosomes of contaminated macrophages and multiplies in these macrophages, leading to the destruction of contaminated macrophages and the emerging of <i>Leishmania</i> wounds. A large number of current therapies for <i>Leishmania</i> cure have adverse effects, or parasites have developed resistance to some of these therapies, so a better therapy for the cure of <i>Leishmania</i> is required. Thymoquinone is one of the <i>Nigella Sativa</i> ingredients with numerous biological effects, such as antioxidant as well as antimicrobial effects on a variety of microbes, namely fungi, bacteria, as well as parasites like <i>Leishmania</i> spp. The impacts of Thymoquinone on <i>Leishmania tropica</i> and <i>Leishmania infantum</i>, as well as <i>Leishmania</i>-infected macrophages, were examined in this study.</p><h3>Methods</h3><p>The impact of various Thymoquinone dosages on <i>L. tropica</i> and <i>L. infantum</i> promastigotes and amastigotes was examined in vitro. Flow cytometry, as well as MTT, was also applied to examine the cytotoxic activity of Thymoquinone on promastigotes of <i>L. tropica</i> and <i>L. infantum</i>, as well as the incidence of apoptosis. The amastigote assay is also utilized to calculate the % of contaminated macrophages as well as the number of the present parasites in each macrophage.</p><h3>Results</h3><p>The percentage of macrophages contaminated with <i>L. tropica</i> and <i>L. infantum</i> amastigotes after medicating with 20 μM of Thymoquinone was 23% and 19%, respectively. Also, after medicating with 10 μM of Thymoquinone, these percentages were 32% and 31%, respectively. Flow cytometry indicated that Thymoquinone caused 33.9% and 31.4% apoptosis in <i>L. tropica and L. infantum</i>, respectively. As determined by the promastigote assay, the inhibitory concentration (IC50) of Thymoquinone for <i>L. tropica</i> and <i>L. infantum</i> was 9.49 μM and 12.66 μM, respectively. The results of the promastigote and amastigote assay show that with an increase in Thymoquinone doses, its ability to kill Leishmania parasites increases, too.</p><h3>Conclusion</h3><p>According to the results of the study, Thymoquinone has a potentially lethal impact on <i>L. tropica</i> and <i>L. infantum</i> promastigotes as well as amastigotes (within <i>leishmania</i> contaminated macrophages).</p></div>","PeriodicalId":6932,"journal":{"name":"Acta Parasitologica","volume":"68 4","pages":"735 - 745"},"PeriodicalIF":1.2000,"publicationDate":"2023-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages\",\"authors\":\"Amir KarimiPourSaryazdi, Mohammad Mahdi Jafari, Majid Pirestani, Seyyed Hojjat Sadeghi, Zeinab Moghadamizad\",\"doi\":\"10.1007/s11686-023-00713-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p><i>Leishmania</i> is a parasitic protozoan that tries to enter and amplify within macrophages. Macrophage cells are also immune defense cells that phagocyte many microbes like bacteria, fungi, as well as parasites like <i>Leishmania</i> spp. However, they are unable to kill this parasite that resides in the phagosomes of contaminated macrophages and multiplies in these macrophages, leading to the destruction of contaminated macrophages and the emerging of <i>Leishmania</i> wounds. A large number of current therapies for <i>Leishmania</i> cure have adverse effects, or parasites have developed resistance to some of these therapies, so a better therapy for the cure of <i>Leishmania</i> is required. Thymoquinone is one of the <i>Nigella Sativa</i> ingredients with numerous biological effects, such as antioxidant as well as antimicrobial effects on a variety of microbes, namely fungi, bacteria, as well as parasites like <i>Leishmania</i> spp. The impacts of Thymoquinone on <i>Leishmania tropica</i> and <i>Leishmania infantum</i>, as well as <i>Leishmania</i>-infected macrophages, were examined in this study.</p><h3>Methods</h3><p>The impact of various Thymoquinone dosages on <i>L. tropica</i> and <i>L. infantum</i> promastigotes and amastigotes was examined in vitro. Flow cytometry, as well as MTT, was also applied to examine the cytotoxic activity of Thymoquinone on promastigotes of <i>L. tropica</i> and <i>L. infantum</i>, as well as the incidence of apoptosis. The amastigote assay is also utilized to calculate the % of contaminated macrophages as well as the number of the present parasites in each macrophage.</p><h3>Results</h3><p>The percentage of macrophages contaminated with <i>L. tropica</i> and <i>L. infantum</i> amastigotes after medicating with 20 μM of Thymoquinone was 23% and 19%, respectively. Also, after medicating with 10 μM of Thymoquinone, these percentages were 32% and 31%, respectively. Flow cytometry indicated that Thymoquinone caused 33.9% and 31.4% apoptosis in <i>L. tropica and L. infantum</i>, respectively. As determined by the promastigote assay, the inhibitory concentration (IC50) of Thymoquinone for <i>L. tropica</i> and <i>L. infantum</i> was 9.49 μM and 12.66 μM, respectively. The results of the promastigote and amastigote assay show that with an increase in Thymoquinone doses, its ability to kill Leishmania parasites increases, too.</p><h3>Conclusion</h3><p>According to the results of the study, Thymoquinone has a potentially lethal impact on <i>L. tropica</i> and <i>L. infantum</i> promastigotes as well as amastigotes (within <i>leishmania</i> contaminated macrophages).</p></div>\",\"PeriodicalId\":6932,\"journal\":{\"name\":\"Acta Parasitologica\",\"volume\":\"68 4\",\"pages\":\"735 - 745\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-08-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Parasitologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s11686-023-00713-x\",\"RegionNum\":3,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PARASITOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Parasitologica","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s11686-023-00713-x","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PARASITOLOGY","Score":null,"Total":0}
Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages
Introduction
Leishmania is a parasitic protozoan that tries to enter and amplify within macrophages. Macrophage cells are also immune defense cells that phagocyte many microbes like bacteria, fungi, as well as parasites like Leishmania spp. However, they are unable to kill this parasite that resides in the phagosomes of contaminated macrophages and multiplies in these macrophages, leading to the destruction of contaminated macrophages and the emerging of Leishmania wounds. A large number of current therapies for Leishmania cure have adverse effects, or parasites have developed resistance to some of these therapies, so a better therapy for the cure of Leishmania is required. Thymoquinone is one of the Nigella Sativa ingredients with numerous biological effects, such as antioxidant as well as antimicrobial effects on a variety of microbes, namely fungi, bacteria, as well as parasites like Leishmania spp. The impacts of Thymoquinone on Leishmania tropica and Leishmania infantum, as well as Leishmania-infected macrophages, were examined in this study.
Methods
The impact of various Thymoquinone dosages on L. tropica and L. infantum promastigotes and amastigotes was examined in vitro. Flow cytometry, as well as MTT, was also applied to examine the cytotoxic activity of Thymoquinone on promastigotes of L. tropica and L. infantum, as well as the incidence of apoptosis. The amastigote assay is also utilized to calculate the % of contaminated macrophages as well as the number of the present parasites in each macrophage.
Results
The percentage of macrophages contaminated with L. tropica and L. infantum amastigotes after medicating with 20 μM of Thymoquinone was 23% and 19%, respectively. Also, after medicating with 10 μM of Thymoquinone, these percentages were 32% and 31%, respectively. Flow cytometry indicated that Thymoquinone caused 33.9% and 31.4% apoptosis in L. tropica and L. infantum, respectively. As determined by the promastigote assay, the inhibitory concentration (IC50) of Thymoquinone for L. tropica and L. infantum was 9.49 μM and 12.66 μM, respectively. The results of the promastigote and amastigote assay show that with an increase in Thymoquinone doses, its ability to kill Leishmania parasites increases, too.
Conclusion
According to the results of the study, Thymoquinone has a potentially lethal impact on L. tropica and L. infantum promastigotes as well as amastigotes (within leishmania contaminated macrophages).
期刊介绍:
Acta Parasitologica is an international journal covering the latest advances in the subject.
Acta Parasitologica publishes original papers on all aspects of parasitology and host-parasite relationships, including the latest discoveries in biochemical and molecular biology of parasites, their physiology, morphology, taxonomy and ecology, as well as original research papers on immunology, pathology, and epidemiology of parasitic diseases in the context of medical, veterinary and biological sciences. The journal also publishes short research notes, invited review articles, book reviews.
The journal was founded in 1953 as "Acta Parasitologica Polonica" by the Polish Parasitological Society and since 1954 has been published by W. Stefanski Institute of Parasitology of the Polish Academy of Sciences in Warsaw. Since 1992 in has appeared as Acta Parasitologica in four issues per year.